Jan 4 (Reuters) - Third Harmonic Bio Inc THRD.O :
* THIRD HARMONIC BIO APPOINTS CHRISTOPHER MURPHY AS CHIEF
FINANCIAL AND BUSINESS OFFICER AND PROVIDES BUSINESS UPDATE
* IND-ENABLING TOXICOLOGY STUDIES OF THB335 NEARING
COMPLETION;
PRE-IND INTERACTION WITH U.S. FDA NOW COMPLETE
* PROGRAM REMAINS ON TRACK TO FILE A U.S. IND AND INITIATE A
PHASE
1 STUDY OF THB335 DURING FIRST HALF OF 2024
* MAINTAINS A STRONG FINANCIAL POSITION WITH CASH AND CASH
EQUIVALENTS TOTALING $273.9 MILLION AS OF SEPTEMBER 30, 2023
Source text for Eikon: ID:nGNXbWQ439
Further company coverage: THRD.O
((Reuters.Briefs@thomsonreuters.com;))